Loading...
Simvastatin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Simvastatin
2025-Q4
Comprehensive analysis of India’s simvastatin export trade — suppliers, buyers, prices, routes, and every shipment record.
208
Shipments
$5.24M
Trade Value
35
Suppliers
30
Buyers
32
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/simvastatin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s simvastatin trade — 2025-Q4
KEY TAKEAWAY
Simvastatin 2025-Q4 exports total $5.2M across 32 countries, with LUPIN LTD commanding 52.3% market share.
TOTAL SHIPMENTS
208
2025-Q4
EXPORT VALUE
$5.2M
FOB USD
TOTAL QUANTITY
147.1M
units shipped
INDIAN SUPPLIERS
35
unique exporters
GLOBAL BUYERS
30
unique importers
DESTINATIONS
32
countries
MEDIAN UNIT PRICE
$0.632
per unit
TOP-5 SHARE
90.2%
of total USD
BRANDED SHARE
43.8%
91 shipments
DOSAGE FORMS
1
product types
6 KEY FINDINGS
1
LUPIN LTD is India's #1 Simvastatin exporter with $2.7M (52.3% market share).→ §5, Indian Supplier Rankings
2
Simvastatin reached 32 countries, with United States as the top destination ($2.7M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 3249) — top 10 suppliers control 97.1% of exports.→ §5, Indian Supplier Rankings
4
90.0% of buyers (27 of 30) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (100.0%) across 1 dosage forms.→ §7, Price Benchmarks
6
32 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 LUPIN LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian simvastatin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Simvastatin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial simvastatin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian simvastatin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Simvastatin India trade report
Product scope
Simvastatin
All variants merged — branded and generic formulations of simvastatin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
208
Every commercial simvastatin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $2.3M, Nov $1.6M, Dec $1.4M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$2.3M
Oct USD
63 shipments
2
$1.6M
Nov USD
-32.1% MoM
3
$1.4M
Dec USD
-13.3% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 32.1% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $2.3M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $5.2M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $742K dip in Nov, $208K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $2.3M | 63 shipments |
| Nov | $1.6M | 81 shipments |
| Dec | $1.4M | 64 shipments |
| Q4 Total | $5.2M | 208 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: LUPIN LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import simvastatin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 52.3% of India’s 2025-Q4 simvastatin trade ($2.7M). Beyond the top 10 destinations, 32 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Europe has 9 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 32 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much simvastatin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$197K
3.8% of trade
5 countries · 34 shipments
Europe
$1.9M
36.1% of trade
9 countries · 61 shipments
Americas
$2.9M
54.6% of trade
8 countries · 90 shipments
Africa
$8K
0.1% of trade
5 countries · 8 shipments
Oceania
$282K
5.4% of trade
5 countries · 15 shipments
Fig 4.1 United States is the #1 corridor ($2.7M) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian simvastatin it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $2.7M | 70 | LUPIN LTD | $2.7M | — | — | — | — |
| 2 | Belgium | $1.0M | 27 | SUN PHARMACEUTICAL INDUSTRIES LTD | $1.0M | — | — | — | — |
| 3 | United Kingdom | $373K | 6 | MICRO LABS LTD | $373K | — | — | — | — |
| 4 | Hungary | $222K | 3 | MYLAN LABORATORIES LTD | $222K | — | — | — | — |
| 5 | Australia | $171K | 11 | MYLAN LABORATORIES LTD | $95K | CIPLA LTD | $76K | — | — |
| 6 | Malta | $152K | 15 | AUROBINDO PHARMA LTD | $152K | TORRENT PHARMACEUTICALS LTD | $2 | — | — |
| 7 | Fiji | $103K | 1 | BAFNA PHARMACEUTICALS LTD | $103K | — | — | — | — |
| 8 | Lebanon | $98K | 1 | MILAN LABORATORIES (INDIA) PVT LTD | $98K | — | — | — | — |
| 9 | Philippines | $65K | 6 | CELOGEN PHARMA PVT LTD | $37K | CENTURION LABORATORIES PVT LTD | $28K | — | — |
| 10 | France | $52K | 6 | AUROBINDO PHARMA LTD | $52K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 3.8% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
52.3%
#1 country share
United States alone
86.6%
Top 5 share
5 of 32 countries
98.8%
Top 15 share
Long tail of 17 countries = 1.2%
HHI 3225
Destination HHI
Highly concentrated
32
Countries served
Global pharma reach from India
9
Europe countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
35 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
LUPIN LTD ($2.7M, 52.3% share) and SUN PHARMACEUTICAL INDUSTRIES LTD ($1.0M) together control 72.0% of India’s 2025-Q4 simvastatin trade. The top 5 suppliers hold 90.2%. 35 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian simvastatin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 LUPIN LTD leads by $1.7M over SUN PHARMACEUTICAL INDUSTRIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: RYVIS PHARMA PVT is #15 by value but #7 by volume.
Fig 5.2 LUPIN LTD also leads by shipment count (70) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: RYVIS PHARMA PVT moves from #7 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 35 simvastatin suppliers split into strategic segments
KEY TAKEAWAY
9 suppliers (25%) generate 96.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 LUPIN LTD and SUN PHARMACEUTICAL INDUSTRIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 96.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | LUPIN LTD | 1 | 1 | $2.7M |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | 1 | 1 | $1.0M |
| 3 | MICRO LABS LTD | 1 | 1 | $373K |
| 4 | MYLAN LABORATORIES LTD | 1 | 3 | $317K |
| 5 | AUROBINDO PHARMA LTD | 1 | 4 | $260K |
| 6 | BAFNA PHARMACEUTICALS LTD | 1 | 1 | $103K |
| 7 | MILAN LABORATORIES (INDIA) PVT LTD | 1 | 1 | $98K |
| 8 | CIPLA LTD | 1 | 1 | $76K |
| 9 | THERDOSE PHARMA PVT LTD | 1 | 1 | $49K |
| 10 | CELOGEN PHARMA PVT LTD | 1 | 1 | $37K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the simvastatin manufacturing hubs
KEY TAKEAWAY
Mumbai and Hosur together account for $4.0M of India’s 2025-Q4 simvastatin trade.
Fig 5.5 Mumbai (9 exporters, $3.7M) and Hosur (1 exporters, $373K) are India’s simvastatin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
90.2%
Top 5 share
5 of 35 suppliers
97.1%
Top 10 share
10 of 35 suppliers
96.4%
Top 25% share
9 suppliers = 96% USD
HHI 3249
Supplier HHI
Concentrated
35
Total suppliers
shipped Simvastatin in 2025-Q4
20+ cities
Indian hubs
Mumbai and Hosur lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MYLAN LABORATORIES LTD | $317K |
| #2 | AUROBINDO PHARMA LTD | $260K |
#4
EXPORTER PROFILE #1 OF 2
MYLAN LABORATORIES LTD
Hyderabad · India’s #4 simvastatin supplier by USD · 2025-Q4
2025-Q4 USD
$317K
6.1% market share
SHIPMENTS
7
avg $45K/ship
COUNTRIES
3
destination markets
BUYERS
3
3 single-sourced
BRANDED
43%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
Hungary is the #1 market at $222K (70% of trade), followed by Australia at $95K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Hungary | $222K | 3 | 70.0% |
| 2 | Australia | $95K | 3 | 29.9% |
| 3 | Netherlands | $70 | 1 | 0.0% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $219K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MYLAN HUNGARY KFT | Hungary | $222K | ⚠ Locked |
| ALPHAPHARM PTY LTD | Australia | $95K | ⚠ Locked |
| MYLAN B.V | Netherlands | $70 | ⚠ Locked |
#4
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
MYLAN LABORATORIES LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 Hungary absorbs $222K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
#5
EXPORTER PROFILE #2 OF 2
AUROBINDO PHARMA LTD
Hyderabad · India’s #5 simvastatin supplier by USD · 2025-Q4
2025-Q4 USD
$260K
5.0% market share
SHIPMENTS
24
avg $11K/ship
COUNTRIES
4
destination markets
BUYERS
5
5 single-sourced
BRANDED
25%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Malta is the #1 market at $152K (58% of trade), followed by France at $52K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Malta | $152K | 13 | 58.3% |
| 2 | France | $52K | 6 | 20.1% |
| 3 | Finland | $31K | 1 | 12.0% |
| 4 | Canada | $25K | 4 | 9.6% |
MONTHLY TREND
Oct peaked at $137K. Nov was the weakest at $31K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| APL SWIFT SERVICES (MA… | Malta | $152K | ⚠ Locked |
| ARROW GENERIQUES, 26 A… | France | $41K | ⚠ Locked |
| ORION CORP | Finland | $31K | ⚠ Locked |
| AURO PHARMA INC | Canada | $25K | ⚠ Locked |
| ARROW GENERIQUES | France | $11K | ⚠ Locked |
#5
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
AUROBINDO PHARMA LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P2.3 Malta absorbs $152K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
30 importers across 32 countries — who is buying Indian simvastatin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 93.7% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian simvastatin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 UPS SUPPLY CHAIN SOLUTIONS INC is the #1 importer at $2.6M (48.9%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
90%
Single-source
27 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source simvastatin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Australia 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ALPHAPHARM PTY LTD | MYLAN LABORATORIES LTD | $95K | $0.016 | Tablet |
| APOTEX AUSTRALIA | CIPLA LTD | $48K | $0.016 | Tablet |
| ARROW PHARMACEUTICALS … | CIPLA LTD | $28K | $0.014 | Tablet |
Malta 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| APL SWIFT SERVICES (MA… | AUROBINDO PHARMA LTD | $152K | $0.013 | Tablet |
| TORRENT PHARMA (MALTA)… | TORRENT PHARMACEUTIC… | $1.574 | $0.787 | Tablet |
France 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ARROW GENERIQUES, 26 A… | AUROBINDO PHARMA LTD | $41K | $0.014 | Tablet |
| ARROW GENERIQUES | AUROBINDO PHARMA LTD | $11K | $0.014 | Tablet |
United States 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| UPS SUPPLY CHAIN SOLUT… | LUPIN LTD | $2.6M | $3.712 | Tablet |
Belgium 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| YUSEN LOGISTICS BENELU… | SUN PHARMACEUTICAL I… | $1.0M | $0.012 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | UPS SUPPLY CHAIN SOL… | United States | $2.6M | $40K | Premium |
| 2 | YUSEN LOGISTICS BENE… | Belgium | $1.0M | $38K | Premium |
| 3 | BROWN AND BURK UK LTD | United Kingdom | $373K | $62K | Premium |
| 4 | MYLAN HUNGARY KFT | Hungary | $222K | $74K | Premium |
| 5 | APL SWIFT SERVICES (… | Malta | $152K | $12K | Budget |
| 6 | ASHABHAI PHARMACEUTI… | Fiji | $103K | $103K | Premium |
| 7 | ALPHAPHARM PTY LTD | Australia | $95K | $32K | Mid |
| 8 | NEW GPC INC | Guyana | $49K | $49K | Premium |
| 9 | APOTEX AUSTRALIA | Australia | $48K | $12K | Budget |
| 10 | ARROW GENERIQUES, 26… | France | $41K | $8K | Budget |
| 11 | ORION CORP | Finland | $31K | $31K | Mid |
| 12 | MEDEK PHARMA S.A | Dominican Republic | $31K | $16K | Mid |
| 13 | ARROW PHARMACEUTICAL… | Australia | $28K | $7K | Budget |
| 14 | PHILGEN PHARMACEUTIC… | Philippines | $28K | $28K | Mid |
| 15 | UNI DRUG HOUSE | Singapore | $27K | $14K | Budget |
| 16 | ASCEND GMBH | Germany | $26K | $26K | Mid |
| 17 | AURO PHARMA INC | Canada | $25K | $6K | Budget |
| 18 | ARROW GENERIQUES | France | $11K | $11K | Budget |
| 19 | RPPL | Jamaica | $8K | $1K | Budget |
| 20 | UNIVERSAL MARKETING … | Nicaragua | $7K | $7K | Budget |
| 21 | LIAONING SA | China | $6K | $6K | Budget |
| 22 | LUA COMERCIO GERAL L… | Angola | $2K | $2K | Budget |
| 23 | EMIRATES POST COMPANY | United Arab Emirates | $791.004 | $53.000 | Budget |
| 24 | REPUBLIC OF NAURU - … | Nauru | $450.809 | $451.000 | Budget |
| 25 | AMDJERAS FIELD HOSPI… | Chad | $71.522 | $72.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 LUPIN LTD → UPS SUPPLY CHAIN SOLUTIONS INC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian simvastatin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Simvastatin prices span 152841× ($0.0049 → $743.68). The coefficient of variation is 5.54. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0049 | Lowest observed unit price |
| P5 | $0.0095 | 5th percentile |
| P25 | $0.016 | 25th percentile (Q1) |
| Median | $0.632 | 50th percentile (Q2) |
| P75 | $3.20 | 75th percentile (Q3) |
| P95 | $29.55 | 95th percentile |
| Max | $743.68 | Highest observed unit price |
| Mean | $15.68 | Arithmetic average |
| CV | 554% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MICRO LABS LTD prices at $621.36/unit vs market median $0.632.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. SUN PHARMACEUTICAL INDUSTRIES Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. LUPIN LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. THERDOSE PHARMA PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. BAFNA PHARMACEUTICALS LTD Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | MICRO LABS LTD | United Kingdom | Tablet | 93 | $70K | $753.76 | Specialty / small-batch |
| Nov 2025 | MICRO LABS LTD | United Kingdom | Tablet | 93 | $69K | $744.35 | Specialty / small-batch |
| Nov 2025 | MICRO LABS LTD | United Kingdom | Tablet | 93 | $69K | $743.68 | Specialty / small-batch |
| Dec 2025 | MICRO LABS LTD | United Kingdom | Tablet | 95 | $55K | $580.65 | Specialty / small-batch |
| Dec 2025 | MICRO LABS LTD | United Kingdom | Tablet | 94 | $55K | $580.58 | Specialty / small-batch |
| Dec 2025 | MICRO LABS LTD | United Kingdom | Tablet | 94 | $54K | $580.53 | Specialty / small-batch |
| Dec 2025 | LUPIN LTD | United States | Tablet | 480 | $15K | $31.26 | Specialty / small-batch |
| Nov 2025 | LUPIN LTD | United States | Tablet | 960 | $29K | $30.60 | Specialty / small-batch |
| Nov 2025 | LUPIN LTD | United States | Tablet | 960 | $29K | $30.60 | Specialty / small-batch |
| Nov 2025 | LUPIN LTD | United States | Tablet | 960 | $29K | $30.60 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | SUN PHARMACEUTIC… | Belgium | Tablet | 435K | $2K | $0.0049 | Bulk generic tablet |
| Dec 2025 | MYLAN LABORATORI… | Hungary | Tablet | 8.1M | $47K | $0.0057 | Bulk generic tablet |
| Dec 2025 | MYLAN LABORATORI… | Hungary | Tablet | 13.6M | $78K | $0.0057 | Bulk generic tablet |
| Nov 2025 | SUN PHARMACEUTIC… | Belgium | Tablet | 7.9M | $51K | $0.0065 | Bulk generic tablet |
| Nov 2025 | SUN PHARMACEUTIC… | Belgium | Tablet | 4.1M | $27K | $0.0065 | Bulk generic tablet |
| Nov 2025 | IPCA LABORATORIE… | New Zealand | Tablet | 1.1M | $8K | $0.0070 | Bulk generic tablet |
| Oct 2025 | AUROBINDO PHARMA… | Malta | Tablet | 1K | $10.95 | $0.0074 | Bulk generic tablet |
| Dec 2025 | AMBIX HEALTHCARE… | Portugal | Tablet | 2K | $13.44 | $0.0081 | Bulk generic tablet |
| Oct 2025 | SUN PHARMACEUTIC… | Belgium | Tablet | 4.1M | $38K | $0.0095 | Bulk generic tablet |
| Nov 2025 | SUN PHARMACEUTIC… | Belgium | Tablet | 8.2M | $77K | $0.0095 | Bulk generic tablet |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship simvastatin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Simvastatin leaves India through 20+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), DADRI ICD, CMA CGM LOGISTICS ICD) handle 87.1% of total USD. SEA moves 49% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $3.1M — top 20 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Louisville is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 49% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$3.5M
67.4% of USD · 48.6% of ships
ICD
$1.4M
27.3% of USD · 25.0% of ships
AIR
$278K
5.3% of USD · 26.4% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → N. America ($2.7M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United States is the most concentrated destination (HHI 10000, 1 suppliers). Australia is the most competitive (HHI 5062).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United States (HHI 10,000) is the most concentrated — Australia (HHI 5,062) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| UPS SUPPLY CHAIN SOL… | United States | LUPIN LTD | $2.6M | 64 | CRITICAL |
| YUSEN LOGISTICS BENE… | Belgium | SUN PHARMACEUTIC… | $1.0M | 27 | CRITICAL |
| BROWN AND BURK UK LTD | United Kingdom | MICRO LABS LTD | $373K | 6 | HIGH |
| MYLAN HUNGARY KFT | Hungary | MYLAN LABORATORI… | $222K | 3 | HIGH |
| APL SWIFT SERVICES (… | Malta | AUROBINDO PHARMA… | $152K | 13 | HIGH |
| ASHABHAI PHARMACEUTI… | Fiji | BAFNA PHARMACEUT… | $103K | 1 | HIGH |
| ALPHAPHARM PTY LTD | Australia | MYLAN LABORATORI… | $95K | 3 | MEDIUM |
| NEW GPC INC | Guyana | THERDOSE PHARMA … | $49K | 1 | MEDIUM |
Conclusion: 27 buyers depend on exactly one Indian supplier, representing $4.9M in trade. 2 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Belgium | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Hungary | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Malta | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Fiji | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Finland | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Dominican Republic | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit United States lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (1 suppliers) | This Q | HIGH |
| A6 | Enter Belgium (1 suppliers) | This Q | MED |
| A8 | Build Belgium distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 1 | $2.7M | -53.6% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Belgium | Other | 1 | $1.0M | -92.8% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Australia | Other | 2 | $171K | +195% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | United Kingdom | Other | 1 | $373K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Canada | Other | 1 | $25K | +1152.4% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Hungary | Other | 1 | $222K | +27% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Malta | Other | 2 | $152K | -37.2% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Fiji | Other | 1 | $103K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Lebanon | Other | 1 | $98K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Philippines | Asia | 2 | $65K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | France | Other | 1 | $52K | -75% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Guyana | Other | 2 | $50K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Finland | Other | 1 | $31K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Dominican Republic | Other | 1 | $31K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Singapore | Asia | 1 | $27K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 208 2025-Q4 Simvastatin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/simvastatin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 208 2025-Q4 simvastatin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian simvastatin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
208
across all regions
TOTAL USD
$5.24M
2025-Q4 FOB value
UNITS
147.1M
tablets, capsules, etc.
SUPPLIERS
35
Indian exporters
BUYERS
30
global importers
COUNTRIES
32
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $8K (0.1%), spanning 5 countries.
35 Indian suppliers shipped to 30 buyers across 32 countries — average shipment value $25K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
5 countries · 8 shipments · $8K · 6 Indian suppliers · 4 buyers
SHIPMENTS
8
USD
$8K
COUNTRIES
5
SUPPLIERS
6
BUYERS
4
HHI
2,763
concentrated
Top 5 destination countries in Africa
1
Nigeria (39.5%)
$3K
2
Angola (37.9%)
$3K
3
Mozambique (21.6%)
$2K
4
Chad (0.9%)
$71.52
5
Zimbabwe (0.1%)
$6.12
Top 6 Indian suppliers into Africa
1
LABORATE PHARMACEUTICALS INDIA LTD
$3K
2
AURA LIFECARE PVT LTD
$2K
3
GLOBAL PHARMA HEALTHCARE PVT LTD
$2K
4
VIAN INTERNATIONAL
$1K
5
AKASH PHARMA EXPORTS
$71.52
6
RUTVA MEDICARE
$6.12
Top 2 Africa importers
1
LUA COMERCIO GERAL LIMITADA · Angola
$2K
2
AMDJERAS FIELD HOSPITAL · Chad
$71.52
Top 2 dosage forms
1
Tablet
$6K
2
Unknown
$2K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $1K | $425.20 |
| Nov | 3 | $5K | $2K |
| Dec | 2 | $2K | $838.30 |
Shipment register · 8 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LABORATE PHARMACEUTICALS INDIA LTD · 2 shipments · $3K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Nigeria | Tablet | 621 | NOS | $2.41 | $1K | PATLI ICD | Apapa | ICD |
| 2 | Nov 2025 | UNKNOWN BUYER | Nigeria | Tablet | 621 | NOS | $2.41 | $1K | PATLI ICD | Apapa | ICD |
| SUPPLIER #2 — AURA LIFECARE PVT LTD · 1 shipments · $2K | |||||||||||
| 3 | Dec 2025 | LUA COMERCIO GERAL LIMITADA | Angola | Tablet | 1.6K | NOS | $1.02 | $2K | MUNDRA SEA | Luanda | SEA |
| SUPPLIER #3 — GLOBAL PHARMA HEALTHCARE PVT LTD · 1 shipments · $2K | |||||||||||
| 4 | Nov 2025 | UNLISTED BUYER | Mozambique | 783 | NOS | $2.10 | $2K | KATTUPALLI PORT SEA | Maputo | SEA | |
| SUPPLIER #4 — VIAN INTERNATIONAL · 2 shipments · $1K | |||||||||||
| 5 | Oct 2025 | UNLISTED BUYER | Angola | Tablet | 290 | PCS | $1.90 | $550.44 | AHMEDABAD AIR | LUANDA - | AIR |
| 6 | Oct 2025 | UNLISTED BUYER | Angola | Tablet | 290 | PCS | $2.25 | $653.64 | AHMEDABAD AIR | LUANDA - | AIR |
| SUPPLIER #5 — AKASH PHARMA EXPORTS · 1 shipments · $71.52 | |||||||||||
| 7 | Oct 2025 | AMDJERAS FIELD HOSPITAL | Chad | Tablet | 30 | NOS | $2.38 | $71.52 | COCHIN SEA | N'DJAMENA | AIR |
| SUPPLIER #6 — RUTVA MEDICARE · 1 shipments · $6.12 | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 20 | PCS | $0.306 | $6.12 | AHMEDABAD AIR | HARARE | AIR | |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 34 shipments · $197K · 9 Indian suppliers · 7 buyers
SHIPMENTS
34
USD
$197K
COUNTRIES
5
SUPPLIERS
9
BUYERS
7
HHI
3,230
concentrated
Top 5 destination countries in Asia
1
Lebanon (49.7%)
$98K
2
Philippines (33.0%)
$65K
3
Singapore (13.9%)
$27K
4
China (3.0%)
$6K
5
United Arab Emirates (0.4%)
$818.40
Top 9 Indian suppliers into Asia
1
MILAN LABORATORIES (INDIA) PVT LTD
$98K
2
CELOGEN PHARMA PVT LTD
$37K
3
CENTURION LABORATORIES PVT LTD
$28K
4
J B CHEMICALS AND PHARMACEUTICALS LTD
$27K
5
GRECIAN PVT LTD
$6K
6
DERRIC WOOD
$791.00
7
PREMIER ENTERPRISE
$18.77
8
MOVID IMPEX
$7.06
9
MDS ENTERPRISES
$1.57
Top 5 Asia importers
1
PHILGEN PHARMACEUTICALS INC · Philippines
$28K
2
UNI DRUG HOUSE · Singapore
$27K
3
LIAONING SA · China
$6K
4
EMIRATES POST COMPANY · United Arab Emirates
$791.00
5
EMIRATES POST GROUP · United Arab Emirates
$25.83
Top 2 dosage forms
1
Tablet
$197K
2
Unknown
$2.35
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $27K | $14K |
| Nov | 26 | $72K | $3K |
| Dec | 6 | $98K | $16K |
Shipment register · 34 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MILAN LABORATORIES (INDIA) PVT LTD · 1 shipments · $98K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 11.4K | NOS | $8.60 | $98K | NHAVA SHEVA SEA (JNPT) | Beirut | SEA |
| SUPPLIER #2 — CELOGEN PHARMA PVT LTD · 5 shipments · $37K | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Philippines | Tablet | 63.6K | NOS | $0.160 | $10K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Philippines | Tablet | 63.6K | NOS | $0.160 | $10K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 4 | Nov 2025 | UNLISTED BUYER | Philippines | Tablet | 65.1K | NOS | $0.141 | $9K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Philippines | Tablet | 54.8K | NOS | $0.141 | $8K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 6 | Nov 2025 | UNLISTED BUYER | Philippines | Tablet | 10 | NOS | $0.141 | $1.41 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #3 — CENTURION LABORATORIES PVT LTD · 1 shipments · $28K | |||||||||||
| 7 | Nov 2025 | PHILGEN PHARMACEUTICALS INC | Philippines | Tablet | 20.0K | NOS | $1.38 | $28K | NHAVA SHEVA SEA (JNPT) | Manila | SEA |
| SUPPLIER #4 — J B CHEMICALS AND PHARMACEUTICALS LTD · 2 shipments · $27K | |||||||||||
| 8 | Oct 2025 | UNI DRUG HOUSE | Singapore | Tablet | 14.8K | NOS | $1.11 | $16K | NHAVA SHEVA SEA (JNPT) | Singapore | SEA |
| 9 | Oct 2025 | UNI DRUG HOUSE | Singapore | Tablet | 16.2K | NOS | $0.681 | $11K | NHAVA SHEVA SEA (JNPT) | Singapore | SEA |
| SUPPLIER #5 — GRECIAN PVT LTD · 1 shipments · $6K | |||||||||||
| 10 | Nov 2025 | LIAONING SA | China | Tablet | 246.0K | PCS | $0.024 | $6K | SONEPAT ICD | DALIAN | ICD |
| SUPPLIER #6 — DERRIC WOOD · 15 shipments · $791.00 | |||||||||||
| 11 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $1.97 | $17.71 | DELHI AIR | DUBAI | AIR |
| 12 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.42 | $30.80 | DELHI AIR | DUBAI | AIR |
| 13 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.42 | $30.80 | DELHI AIR | DUBAI | AIR |
| 14 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 24 | PCS | $1.95 | $46.91 | DELHI AIR | DUBAI | AIR |
| 15 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $1.96 | $35.33 | DELHI AIR | DUBAI | AIR |
| 16 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.20 | $57.64 | DELHI AIR | DUBAI | AIR |
| 17 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 27 | PCS | $3.20 | $86.44 | DELHI AIR | DUBAI | AIR |
| 18 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 27 | PCS | $3.20 | $86.44 | DELHI AIR | DUBAI | AIR |
| 19 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 45 | PCS | $1.96 | $88.33 | DELHI AIR | DUBAI | AIR |
| 20 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 45 | PCS | $1.98 | $88.95 | DELHI AIR | DUBAI | AIR |
| 21 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.38 | $60.88 | DELHI AIR | DUBAI | AIR |
| 22 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.38 | $60.88 | DELHI AIR | DUBAI | AIR |
| 23 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $0.033 | $0.293 | DELHI AIR | DUBAI | AIR |
| 24 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $2.13 | $38.43 | DELHI AIR | DUBAI | AIR |
| 25 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.40 | $61.19 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #7 — PREMIER ENTERPRISE · 1 shipments · $18.77 | |||||||||||
| 26 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 40 | NOS | $0.469 | $18.77 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #8 — MOVID IMPEX · 6 shipments · $7.06 | |||||||||||
| 27 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 6 | NOS | $0.279 | $1.67 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 28 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 3 | NOS | $0.227 | $0.681 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 29 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 6 | NOS | $0.279 | $1.67 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 30 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 3 | NOS | $0.227 | $0.681 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 31 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | 6 | NOS | $0.279 | $1.67 | MUMBAI AIR (SAHAR) | DUBAI | AIR | |
| 32 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | 3 | NOS | $0.227 | $0.681 | MUMBAI AIR (SAHAR) | DUBAI | AIR | |
| SUPPLIER #9 — MDS ENTERPRISES · 2 shipments · $1.57 | |||||||||||
| 33 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 50 | NOS | $0.014 | $0.723 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 50 | NOS | $0.017 | $0.849 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
9 countries · 61 shipments · $1.89M · 7 Indian suppliers · 11 buyers
SHIPMENTS
61
USD
$1.89M
COUNTRIES
9
SUPPLIERS
7
BUYERS
11
HHI
3,671
concentrated
Top 9 destination countries in Europe
1
Belgium (54.6%)
$1.03M
2
United Kingdom (19.7%)
$373K
3
Hungary (11.8%)
$222K
4
Malta (8.0%)
$152K
5
France (2.8%)
$52K
6
Finland (1.7%)
$31K
7
Germany (1.4%)
$26K
8
Netherlands (0.0%)
$69.58
9
Portugal (0.0%)
$13.44
Top 7 Indian suppliers into Europe
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$1.03M
2
MICRO LABS LTD
$373K
3
AUROBINDO PHARMA LTD
$235K
4
MYLAN LABORATORIES LTD
$222K
5
ALKEM LABORATORIES LTD
$26K
6
AMBIX HEALTHCARE LLP
$13.44
7
TORRENT PHARMACEUTICALS LTD
$1.57
Top 10 Europe importers
1
YUSEN LOGISTICS BENELUX BELGIUM · Belgium
$1.03M
2
BROWN AND BURK UK LTD · United Kingdom
$373K
3
MYLAN HUNGARY KFT · Hungary
$222K
4
APL SWIFT SERVICES (MALTA) LTD · Malta
$152K
5
ARROW GENERIQUES, 26 AVENUE TONY · France
$41K
6
ORION CORP · Finland
$31K
7
ASCEND GMBH · Germany
$26K
8
ARROW GENERIQUES · France
$11K
9
MYLAN B.V · Netherlands
$69.58
10
TORRENT PHARMA (MALTA) LTD · Malta
$1.57
Top 1 dosage forms
1
Tablet
$1.89M
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 30 | $897K | $30K |
| Nov | 13 | $589K | $45K |
| Dec | 18 | $403K | $22K |
Shipment register · 61 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 27 shipments · $1.03M | |||||||||||
| 1 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.016 | $68K | DADRI ICD | ANTWERPEN | ICD |
| 2 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.016 | $68K | DADRI ICD | ANTWERPEN | ICD |
| 3 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 1.1M | NOS | $0.019 | $21K | DADRI ICD | ANTWERPEN | ICD |
| 4 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 159.2K | NOS | $0.021 | $3K | DADRI ICD | ANTWERPEN | ICD |
| 5 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.0M | NOS | $0.0097 | $39K | DADRI ICD | ANTWERPEN | ICD |
| 6 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 993.4K | NOS | $0.021 | $21K | DADRI ICD | ANTWERPEN | ICD |
| 7 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.016 | $68K | DADRI ICD | ANTWERPEN | ICD |
| 8 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 1.8M | NOS | $0.019 | $34K | DADRI ICD | ANTWERPEN | ICD |
| 9 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.0097 | $40K | DADRI ICD | ANTWERPEN | ICD |
| 10 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 130.3K | NOS | $0.020 | $3K | DADRI ICD | ANTWERPEN | ICD |
| 11 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 1.9M | NOS | $0.015 | $28K | DADRI ICD | ANTWERPEN | ICD |
| 12 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.2M | NOS | $0.0097 | $40K | DADRI ICD | ANTWERPEN | ICD |
| 13 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 1.9M | NOS | $0.019 | $36K | DADRI ICD | ANTWERPEN | ICD |
| 14 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.2M | NOS | $0.016 | $69K | DADRI - STTPL (CFS) | ANTWERPEN | ICD |
| 15 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 2.1M | NOS | $0.016 | $34K | DADRI ICD | ANTWERPEN | ICD |
| 16 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 1.4M | NOS | $0.021 | $28K | DADRI ICD | ANTWERPEN | ICD |
| 17 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.0095 | $38K | DADRI ICD | Antwerpen | ICD |
| 18 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 7.9M | NOS | $0.0065 | $51K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 19 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 8.2M | NOS | $0.0095 | $77K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 20 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 2.1M | NOS | $0.016 | $33K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 21 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 6.2M | NOS | $0.0095 | $58K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 22 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 215.6K | NOS | $0.014 | $3K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 23 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.0065 | $27K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 24 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 6.2M | NOS | $0.016 | $99K | CMA CGM LOGISTICS ICD | ANTWERPEN | ICD |
| 25 | Dec 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 4.1M | NOS | $0.0097 | $40K | STARTRACK TERMINAL ICD | ANTWERPEN | ICD |
| 26 | Dec 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 257.1K | NOS | $0.016 | $4K | DELHI AIR | BRUSSELS | AIR |
| 27 | Dec 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 434.8K | NOS | $0.0049 | $2K | DELHI AIR | BRUSSELS | AIR |
| SUPPLIER #2 — MICRO LABS LTD · 6 shipments · $373K | |||||||||||
| 28 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Tablet | 93 | KGS | $744.35 | $69K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 29 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Tablet | 93 | KGS | $743.68 | $69K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 30 | Nov 2025 | BROWN AND BURK UK LTD | United Kingdom | Tablet | 93 | KGS | $753.76 | $70K | KAMARAJAR PORT SEA | LONDON GATWAY PORT | SEA |
| 31 | Dec 2025 | BROWN AND BURK UK LTD | United Kingdom | Tablet | 94 | KGS | $580.53 | $54K | HOSUR ICD | LONDON GATWAY PORT | ICD |
| 32 | Dec 2025 | BROWN AND BURK UK LTD | United Kingdom | Tablet | 95 | KGS | $580.65 | $55K | HOSUR ICD | LONDON GATWAY PORT | ICD |
| 33 | Dec 2025 | BROWN AND BURK UK LTD | United Kingdom | Tablet | 94 | KGS | $580.58 | $55K | HOSUR ICD | LONDON GATWAY PORT | ICD |
| SUPPLIER #3 — AUROBINDO PHARMA LTD · 20 shipments · $235K | |||||||||||
| 34 | Oct 2025 | ARROW GENERIQUES, 26 AVENUE TONY | France | Tablet | 176.4K | NOS | $0.021 | $4K | HYDERABAD ICD | FOS SUR MER | ICD |
| 35 | Oct 2025 | ARROW GENERIQUES, 26 AVENUE TONY | France | Tablet | 176.4K | NOS | $0.021 | $4K | HYDERABAD ICD | Fos sur Mer | ICD |
| 36 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 1.7M | NOS | $0.015 | $25K | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 37 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 4.4M | NOS | $0.012 | $54K | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 38 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 1.5K | NOS | $0.010 | $15.19 | HYDERABAD AIR | MALTA | AIR |
| 39 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 1.5K | NOS | $0.0074 | $10.95 | HYDERABAD AIR | MALTA | AIR |
| 40 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 623.7K | NOS | $0.018 | $11K | HYDERABAD ICD | Malta (Valetta) | ICD |
| 41 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 279.0K | NOS | $0.012 | $3K | HYDERABAD ICD | Malta (Valetta) | ICD |
| 42 | Oct 2025 | ARROW GENERIQUES | France | Tablet | 813.1K | NOS | $0.014 | $11K | HYDERABAD ICD | Fos sur Mer | ICD |
| 43 | Oct 2025 | ARROW GENERIQUES, 26 AVENUE TONY | France | Tablet | 781.2K | NOS | $0.013 | $10K | HYDERABAD ICD | Fos sur Mer | ICD |
| 44 | Oct 2025 | ARROW GENERIQUES, 26 AVENUE TONY | France | Tablet | 924.0K | NOS | $0.014 | $13K | HYDERABAD ICD | Fos sur Mer | ICD |
| 45 | Nov 2025 | ORION CORP | Finland | Tablet | 522.1K | NOS | $0.060 | $31K | VIZAG SEA | HELSINKI (HELSINGFOR | SEA |
| 46 | Dec 2025 | ARROW GENERIQUES, 26 AVENUE TONY | France | Tablet | 806.4K | NOS | $0.013 | $10K | HYDERABAD ICD | FOS SUR MER | ICD |
| 47 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 2.2M | NOS | $0.013 | $28K | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 48 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 936.0K | NOS | $0.013 | $12K | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 49 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 516.7K | NOS | $0.012 | $6K | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 50 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 230.9K | NOS | $0.012 | $3K | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 51 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 24.0K | NOS | $0.014 | $343.19 | HYDERABAD ICD | MALTA (VALETTA) | ICD |
| 52 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 516.7K | NOS | $0.012 | $6K | HYDERABAD ICD | Malta (Valetta) | ICD |
| 53 | Dec 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Tablet | 230.9K | NOS | $0.012 | $3K | HYDERABAD ICD | Malta (Valetta) | ICD |
| SUPPLIER #4 — MYLAN LABORATORIES LTD · 4 shipments · $222K | |||||||||||
| 54 | Oct 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 6.8M | NOS | $0.014 | $98K | NHAVA SHEVA SEA (JNPT) | Budapest | SEA |
| 55 | Dec 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 13.6M | NOS | $0.0057 | $78K | MUMBAI AIR (SAHAR) | BUDAPEST, | AIR |
| 56 | Dec 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 8.1M | NOS | $0.0057 | $47K | MUMBAI AIR (SAHAR) | BUDAPEST, | AIR |
| 57 | Dec 2025 | MYLAN B.V | Netherlands | Tablet | 962.0K | NOS | $0.0001 | $69.58 | NHAVA SHEVA SEA (JNPT) | Rotterdam | SEA |
| SUPPLIER #5 — ALKEM LABORATORIES LTD · 1 shipments · $26K | |||||||||||
| 58 | Oct 2025 | ASCEND GMBH | Germany | Tablet | 7.0K | NOS | $3.74 | $26K | NHAVA SHEVA SEA (JNPT) | Heppenheim | SEA |
| SUPPLIER #6 — AMBIX HEALTHCARE LLP · 1 shipments · $13.44 | |||||||||||
| 59 | Dec 2025 | UNLISTED BUYER | Portugal | Tablet | 1.7K | NOS | $0.0081 | $13.44 | NHAVA SHEVA SEA (JNPT) | Lisboa | SEA |
| SUPPLIER #7 — TORRENT PHARMACEUTICALS LTD · 2 shipments · $1.57 | |||||||||||
| 60 | Nov 2025 | TORRENT PHARMA (MALTA) LTD | Malta | Tablet | 1 | NOS | $0.0000 | $0.0000 | DELHI AIR | MALTA | AIR |
| 61 | Nov 2025 | TORRENT PHARMA (MALTA) LTD | Malta | Tablet | 1 | NOS | $1.57 | $1.57 | DELHI AIR | MALTA | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
8 countries · 90 shipments · $2.86M · 9 Indian suppliers · 8 buyers
SHIPMENTS
90
USD
$2.86M
COUNTRIES
8
SUPPLIERS
9
BUYERS
8
HHI
9,171
concentrated
Top 8 destination countries in Americas
1
United States (95.7%)
$2.74M
2
Guyana (1.7%)
$50K
3
Dominican Republic (1.1%)
$31K
4
Canada (0.9%)
$25K
5
Jamaica (0.3%)
$8K
6
Nicaragua (0.2%)
$7K
7
Saint Lucia (0.0%)
$750.35
8
Guatemala (0.0%)
$40.46
Top 9 Indian suppliers into Americas
1
LUPIN LTD
$2.74M
2
THERDOSE PHARMA PVT LTD
$49K
3
VANCE AND HEALTH PHARMACEUTICALS PVT LTD
$31K
4
AUROBINDO PHARMA LTD
$25K
5
RYVIS PHARMA PVT LTD
$8K
6
INTERMED LABORATORIES PVT LTD
$7K
7
NAMAN GLOBAL IMPEX PVT LTD
$750.35
8
PEAK HEALTHCARE
$329.78
9
ASMOH LABORATORIES LTD
$40.46
Top 6 Americas importers
1
UPS SUPPLY CHAIN SOLUTIONS INC · United States
$2.56M
2
NEW GPC INC · Guyana
$49K
3
MEDEK PHARMA S.A · Dominican Republic
$31K
4
AURO PHARMA INC · Canada
$25K
5
RPPL · Jamaica
$8K
6
UNIVERSAL MARKETING ASSOCIATES, S.A · Nicaragua
$7K
Top 1 dosage forms
1
Tablet
$2.86M
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 26 | $1.35M | $52K |
| Nov | 35 | $875K | $25K |
| Dec | 29 | $640K | $22K |
Shipment register · 90 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LUPIN LTD · 70 shipments · $2.74M | |||||||||||
| 1 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 2.9K | NOS | $5.71 | $16K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 2 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.5K | NOS | $8.99 | $58K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 3 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 4.8K | NOS | $13.89 | $67K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 4 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 5.6K | NOS | $13.89 | $78K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 5 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 13.8K | NOS | $14.33 | $198K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 6 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 1.5K | NOS | $9.32 | $14K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 7 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 15.4K | NOS | $14.33 | $220K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 8 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 2.9K | NOS | $5.89 | $17K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 9 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 1.5K | NOS | $9.32 | $14K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 10 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 10.6K | NOS | $14.33 | $152K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 11 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 2.9K | NOS | $5.89 | $17K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 12 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 30.8K | NOS | $1.48 | $46K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 13 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 3.2K | NOS | $14.33 | $47K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 14 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 3.6K | NOS | $2.77 | $10K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 15 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 28.2K | NOS | $1.47 | $41K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 16 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 5.8K | NOS | $2.73 | $16K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 17 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 16.4K | NOS | $9.22 | $151K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 18 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 12.1K | NOS | $0.664 | $8K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 19 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 16.1K | NOS | $0.664 | $11K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 20 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 12.2K | NOS | $2.73 | $33K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 21 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.5K | NOS | $9.22 | $60K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 22 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 16.1K | NOS | $1.47 | $24K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 23 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 480 | NOS | $30.37 | $15K | NHAVA SHEVA SEA (JNPT) | Louisville | SEA |
| 24 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 8.1K | NOS | $0.534 | $4K | MUMBAI AIR (SAHAR) | LOUISVILLE, KY | AIR |
| 25 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 22.3K | NOS | $0.930 | $21K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 26 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 668 | NOS | $30.34 | $20K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 27 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 8.1K | NOS | $0.930 | $8K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 28 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 22.2K | NOS | $0.938 | $21K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 29 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 22.2K | NOS | $0.938 | $21K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 30 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 1.7K | NOS | $14.28 | $24K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 31 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 960 | NOS | $30.60 | $29K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 32 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 1.7K | NOS | $14.28 | $24K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 33 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 960 | NOS | $30.60 | $29K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 34 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 1.7K | NOS | $14.28 | $24K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 35 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 960 | NOS | $30.60 | $29K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 36 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 8.4K | NOS | $5.87 | $49K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 37 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 1.7K | NOS | $14.28 | $24K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 38 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 960 | NOS | $30.60 | $29K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 39 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 8.4K | NOS | $5.87 | $49K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 40 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.1K | NOS | $5.87 | $36K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 41 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.9K | NOS | $0.539 | $4K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 42 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.1K | NOS | $9.29 | $56K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 43 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 8.1K | NOS | $0.599 | $5K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 44 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 4.8K | NOS | $14.28 | $69K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 45 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 8.1K | NOS | $1.18 | $10K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 46 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 34.3K | NOS | $0.669 | $23K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 47 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 36.3K | NOS | $0.939 | $34K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 48 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.5K | NOS | $9.29 | $61K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 49 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 20.0K | NOS | $1.48 | $30K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 50 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 13.8K | NOS | $2.76 | $38K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 51 | Nov 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 3.3K | NOS | $14.28 | $47K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 52 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.5K | NOS | $9.30 | $61K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 53 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 16.3K | NOS | $2.76 | $45K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 54 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 24.2K | NOS | $0.560 | $14K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 55 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 65.9K | NOS | $0.940 | $62K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 56 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 13.0K | NOS | $9.30 | $121K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 57 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 3.2K | NOS | $14.30 | $46K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 58 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.0K | NOS | $0.959 | $6K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 59 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 8.1K | NOS | $1.26 | $10K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 60 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 28.8K | NOS | $0.684 | $20K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 61 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 9.6K | NOS | $9.49 | $91K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 62 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 36.2K | NOS | $1.51 | $55K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 63 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 5.5K | NOS | $0.959 | $5K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 64 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 1.2K | NOS | $9.49 | $11K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 65 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 3.2K | NOS | $14.59 | $47K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 66 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 5.8K | NOS | $0.067 | $385.75 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 67 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 480 | NOS | $0.349 | $167.56 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 68 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 6.5K | NOS | $0.106 | $689.56 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 69 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 180 | NOS | $0.349 | $62.84 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 70 | Dec 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 480 | NOS | $31.26 | $15K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| SUPPLIER #2 — THERDOSE PHARMA PVT LTD · 1 shipments · $49K | |||||||||||
| 71 | Nov 2025 | NEW GPC INC | Guyana | Tablet | 64.7K | NOS | $0.762 | $49K | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #3 — VANCE AND HEALTH PHARMACEUTICALS PVT LTD · 2 shipments · $31K | |||||||||||
| 72 | Oct 2025 | MEDEK PHARMA S.A | Dominican Republic | Tablet | 1.5M | PCS | $0.013 | $19K | MUNDRA SEA | CAUCEDO DOMINIC REP. | SEA |
| 73 | Oct 2025 | MEDEK PHARMA S.A | Dominican Republic | Tablet | 1.0M | PCS | $0.013 | $13K | MUNDRA SEA | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #4 — AUROBINDO PHARMA LTD · 4 shipments · $25K | |||||||||||
| 74 | Oct 2025 | AURO PHARMA INC | Canada | Tablet | 100.8K | NOS | $0.018 | $2K | HYDERABAD ICD | TORONTO | ICD |
| 75 | Dec 2025 | AURO PHARMA INC | Canada | Tablet | 317.7K | NOS | $0.011 | $4K | HYDERABAD ICD | TORONTO | ICD |
| 76 | Dec 2025 | AURO PHARMA INC | Canada | Tablet | 412.8K | NOS | $0.014 | $6K | HYDERABAD ICD | TORONTO | ICD |
| 77 | Dec 2025 | AURO PHARMA INC | Canada | Tablet | 730.7K | NOS | $0.019 | $14K | HYDERABAD ICD | TORONTO | ICD |
| SUPPLIER #5 — RYVIS PHARMA PVT LTD · 6 shipments · $8K | |||||||||||
| 78 | Nov 2025 | RPPL | Jamaica | Tablet | 2.8K | NOS | $0.403 | $1K | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 79 | Nov 2025 | RPPL | Jamaica | Tablet | 2.1K | NOS | $0.191 | $400.52 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 80 | Nov 2025 | RPPL | Jamaica | Tablet | 6.0K | NOS | $0.558 | $3K | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 81 | Nov 2025 | RPPL | Jamaica | Tablet | 2.2K | NOS | $0.261 | $562.72 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 82 | Nov 2025 | RPPL | Jamaica | Tablet | 2.2K | NOS | $0.842 | $2K | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 83 | Nov 2025 | RPPL | Jamaica | Tablet | 2.0K | NOS | $0.373 | $745.03 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| SUPPLIER #6 — INTERMED LABORATORIES PVT LTD · 1 shipments · $7K | |||||||||||
| 84 | Dec 2025 | UNIVERSAL MARKETING ASSOCIATES, S.A | Nicaragua | Tablet | 1.8K | NOS | $3.99 | $7K | CHENNAI SEA | Corinto | SEA |
| SUPPLIER #7 — NAMAN GLOBAL IMPEX PVT LTD · 2 shipments · $750.35 | |||||||||||
| 85 | Dec 2025 | UNKNOWN BUYER | Saint Lucia | Tablet | 150 | NOS | $3.15 | $473.19 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 86 | Dec 2025 | UNKNOWN BUYER | Saint Lucia | Tablet | 100 | NOS | $2.77 | $277.15 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| SUPPLIER #8 — PEAK HEALTHCARE · 3 shipments · $329.78 | |||||||||||
| 87 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 60 | NOS | $2.75 | $164.94 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 88 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 60 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 89 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 60 | NOS | $2.75 | $164.84 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #9 — ASMOH LABORATORIES LTD · 1 shipments · $40.46 | |||||||||||
| 90 | Dec 2025 | UNLISTED BUYER | Guatemala | Tablet | 284.1K | NOS | $0.0001 | $40.46 | MUNDRA SEA | Puerto Quetzal | SEA |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
5 countries · 15 shipments · $282K · 6 Indian suppliers · 6 buyers
SHIPMENTS
15
USD
$282K
COUNTRIES
5
SUPPLIERS
6
BUYERS
6
HHI
3,190
concentrated
Top 5 destination countries in Oceania
1
Australia (60.5%)
$171K
2
Fiji (36.5%)
$103K
3
New Zealand (2.8%)
$8K
4
Nauru (0.2%)
$450.81
5
Papua New Guinea (0.1%)
$198.74
Top 6 Indian suppliers into Oceania
1
BAFNA PHARMACEUTICALS LTD
$103K
2
MYLAN LABORATORIES LTD
$95K
3
CIPLA LTD
$76K
4
IPCA LABORATORIES LTD
$8K
5
HLL LIFECARE LTD
$450.81
6
CHOUDHARI IMPEX
$198.74
Top 5 Oceania importers
1
ASHABHAI PHARMACEUTICAL PTE LTD · Fiji
$103K
2
ALPHAPHARM PTY LTD · Australia
$95K
3
APOTEX AUSTRALIA · Australia
$48K
4
ARROW PHARMACEUTICALS PTY LTD · Australia
$28K
5
REPUBLIC OF NAURU - DEPARTMENT OF H · Nauru
$450.81
Top 1 dosage forms
1
Tablet
$282K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $38K | $19K |
| Nov | 4 | $28K | $7K |
| Dec | 9 | $217K | $24K |
Shipment register · 15 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BAFNA PHARMACEUTICALS LTD · 1 shipments · $103K | |||||||||||
| 1 | Dec 2025 | ASHABHAI PHARMACEUTICAL PTE LTD | Fiji | Tablet | 112.2K | NOS | $0.918 | $103K | CHENNAI SEA | Suva | SEA |
| SUPPLIER #2 — MYLAN LABORATORIES LTD · 3 shipments · $95K | |||||||||||
| 2 | Dec 2025 | ALPHAPHARM PTY LTD | Australia | Tablet | 2.9M | NOS | $0.011 | $32K | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 3 | Dec 2025 | ALPHAPHARM PTY LTD | Australia | Tablet | 1.5M | NOS | $0.022 | $31K | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 4 | Dec 2025 | ALPHAPHARM PTY LTD | Australia | Tablet | 1.5M | NOS | $0.022 | $32K | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| SUPPLIER #3 — CIPLA LTD · 8 shipments · $76K | |||||||||||
| 5 | Oct 2025 | APOTEX AUSTRALIA | Australia | Tablet | 1.1M | NOS | $0.016 | $18K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 6 | Oct 2025 | APOTEX AUSTRALIA | Australia | Tablet | 1.2M | NOS | $0.016 | $20K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 7 | Nov 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 799.2K | NOS | $0.016 | $13K | NHAVA SHEVA SEA (JNPT) | Melbourne | SEA |
| 8 | Nov 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 393.3K | NOS | $0.016 | $6K | NHAVA SHEVA SEA (JNPT) | Melbourne | SEA |
| 9 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 377.4K | NOS | $0.011 | $4K | NHAVA SHEVA SEA (JNPT) | Melbourne | SEA |
| 10 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 374.4K | NOS | $0.011 | $4K | NHAVA SHEVA SEA (JNPT) | Melbourne | SEA |
| 11 | Dec 2025 | APOTEX AUSTRALIA | Australia | Tablet | 375.6K | NOS | $0.014 | $5K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 12 | Dec 2025 | APOTEX AUSTRALIA | Australia | Tablet | 303.6K | NOS | $0.014 | $4K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| SUPPLIER #4 — IPCA LABORATORIES LTD · 1 shipments · $8K | |||||||||||
| 13 | Nov 2025 | UNLISTED BUYER | New Zealand | Tablet | 1.1M | TBS | $0.0070 | $8K | NHAVA SHEVA SEA (JNPT) | Auckland | SEA |
| SUPPLIER #5 — HLL LIFECARE LTD · 1 shipments · $450.81 | |||||||||||
| 14 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Tablet | 22.1K | NOS | $0.020 | $450.81 | DELHI AIR | NAURU ISLAND | AIR |
| SUPPLIER #6 — CHOUDHARI IMPEX · 1 shipments · $198.74 | |||||||||||
| 15 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 1.1K | NOS | $0.181 | $198.74 | CHENNAI AIR | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 35 Indian simvastatin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped simvastatin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | LUPIN LTD | MUMBAI | 70 | $2.74M | Tablet | Americas |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 27 | $1.03M | Tablet | Europe |
| 3 | MICRO LABS LTD | HOSUR | 6 | $373K | Tablet | Europe |
| 4 | MYLAN LABORATORIES LTD | HYDERABAD | 7 | $317K | Tablet | Europe, Oceania |
| 5 | AUROBINDO PHARMA LTD | HYDERABAD | 24 | $260K | Tablet | Americas, Europe |
| 6 | BAFNA PHARMACEUTICALS LTD | VADAKARAI P.OCHENNAI/T.N. | 1 | $103K | Tablet | Oceania |
| 7 | MILAN LABORATORIES (INDIA) PVT LTD | LTD KAMOTHE PANVEL NAVI MUMBAI | 1 | $98K | Tablet | Asia |
| 8 | CIPLA LTD | MUMBAI | 8 | $76K | Tablet | Oceania |
| 9 | THERDOSE PHARMA PVT LTD | PRAGATHI NAGAR | 1 | $49K | Tablet | Americas |
| 10 | CELOGEN PHARMA PVT LTD | NAVI MUMBAI | 5 | $37K | Tablet | Asia |
| 11 | VANCE AND HEALTH PHARMACEUTICALS PVT LTD | ROORKEE | 2 | $31K | Tablet | Americas |
| 12 | CENTURION LABORATORIES PVT LTD | MANJUSAR | 1 | $28K | Tablet | Asia |
| 13 | J B CHEMICALS AND PHARMACEUTICALS LTD | MUMBAI | 2 | $27K | Tablet | Asia |
| 14 | ALKEM LABORATORIES LTD | LOWER PAREL | 1 | $26K | Tablet | Europe |
| 15 | RYVIS PHARMA PVT LTD | Mumbai | 6 | $8K | Tablet | Americas |
| 16 | IPCA LABORATORIES LTD | SILVASSA | 1 | $8K | Tablet | Oceania |
| 17 | INTERMED LABORATORIES PVT LTD | CHENNAI | 1 | $7K | Tablet | Americas |
| 18 | GRECIAN PVT LTD | NEW DELHI | 1 | $6K | Tablet | Asia |
| 19 | LABORATE PHARMACEUTICALS INDIA LTD | PANIPAT | 2 | $3K | Tablet | Africa |
| 20 | AURA LIFECARE PVT LTD | KARACHIYA TAL SAVLI | 1 | $2K | Tablet | Africa |
| 21 | GLOBAL PHARMA HEALTHCARE PVT LTD | KANCHIPURAM THIRUPORUR | 1 | $2K | Africa | |
| 22 | VIAN INTERNATIONAL | SIDHPUR | 2 | $1K | Tablet | Africa |
| 23 | DERRIC WOOD | SUBHASH PLACE | 15 | $791.00 | Tablet | Asia |
| 24 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 2 | $750.35 | Tablet | Americas |
| 25 | HLL LIFECARE LTD | UTTAR PRADESH | 1 | $450.81 | Tablet | Oceania |
| 26 | PEAK HEALTHCARE | MUMBAI | 3 | $329.78 | Tablet | Americas |
| 27 | CHOUDHARI IMPEX | CHENNAI | 1 | $198.74 | Tablet | Oceania |
| 28 | AKASH PHARMA EXPORTS | PALAKKAD | 1 | $71.52 | Tablet | Africa |
| 29 | ASMOH LABORATORIES LTD | DELHI | 1 | $40.46 | Tablet | Americas |
| 30 | PREMIER ENTERPRISE | NAGPUR | 1 | $18.77 | Tablet | Asia |
| 31 | AMBIX HEALTHCARE LLP | MAHESANA | 1 | $13.44 | Tablet | Europe |
| 32 | MOVID IMPEX | MUMBAI | 6 | $7.06 | Tablet | Asia |
| 33 | RUTVA MEDICARE | SURAT | 1 | $6.12 | Africa | |
| 34 | TORRENT PHARMACEUTICALS LTD | SOLAN HIMACHAL PRADESH | 2 | $1.57 | Tablet | Europe |
| 35 | MDS ENTERPRISES | MUMBAI | 2 | $1.57 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 28 global simvastatin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian simvastatin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | 64 | $2.56M | LUPIN LTD | Tablet |
| 2 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | 27 | $1.03M | SUN PHARMACEUTICAL I… | Tablet |
| 3 | BROWN AND BURK UK LTD | United Kingdom | 6 | $373K | MICRO LABS LTD | Tablet |
| 4 | MYLAN HUNGARY KFT | Hungary | 3 | $222K | MYLAN LABORATORIES LTD | Tablet |
| 5 | APL SWIFT SERVICES (MALTA) LTD | Malta | 13 | $152K | AUROBINDO PHARMA LTD | Tablet |
| 6 | ASHABHAI PHARMACEUTICAL PTE LTD | Fiji | 1 | $103K | BAFNA PHARMACEUTICAL… | Tablet |
| 7 | ALPHAPHARM PTY LTD | Australia | 3 | $95K | MYLAN LABORATORIES LTD | Tablet |
| 8 | NEW GPC INC | Guyana | 1 | $49K | THERDOSE PHARMA PVT … | Tablet |
| 9 | APOTEX AUSTRALIA | Australia | 4 | $48K | CIPLA LTD | Tablet |
| 10 | ARROW GENERIQUES, 26 AVENUE TONY | France | 5 | $41K | AUROBINDO PHARMA LTD | Tablet |
| 11 | ORION CORP | Finland | 1 | $31K | AUROBINDO PHARMA LTD | Tablet |
| 12 | MEDEK PHARMA S.A | Dominican Republic | 2 | $31K | VANCE AND HEALTH PHA… | Tablet |
| 13 | ARROW PHARMACEUTICALS PTY LTD | Australia | 4 | $28K | CIPLA LTD | Tablet |
| 14 | PHILGEN PHARMACEUTICALS INC | Philippines | 1 | $28K | CENTURION LABORATORI… | Tablet |
| 15 | UNI DRUG HOUSE | Singapore | 2 | $27K | J B CHEMICALS AND PH… | Tablet |
| 16 | ASCEND GMBH | Germany | 1 | $26K | ALKEM LABORATORIES LTD | Tablet |
| 17 | AURO PHARMA INC | Canada | 4 | $25K | AUROBINDO PHARMA LTD | Tablet |
| 18 | ARROW GENERIQUES | France | 1 | $11K | AUROBINDO PHARMA LTD | Tablet |
| 19 | RPPL | Jamaica | 6 | $8K | RYVIS PHARMA PVT LTD | Tablet |
| 20 | UNIVERSAL MARKETING ASSOCIATES, S.A | Nicaragua | 1 | $7K | INTERMED LABORATORIE… | Tablet |
| 21 | LIAONING SA | China | 1 | $6K | GRECIAN PVT LTD | Tablet |
| 22 | LUA COMERCIO GERAL LIMITADA | Angola | 1 | $2K | AURA LIFECARE PVT LTD | Tablet |
| 23 | EMIRATES POST COMPANY | United Arab Emirates | 15 | $791.00 | DERRIC WOOD | Tablet |
| 24 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | 1 | $450.81 | HLL LIFECARE LTD | Tablet |
| 25 | AMDJERAS FIELD HOSPITAL | Chad | 1 | $71.52 | AKASH PHARMA EXPORTS | Tablet |
| 26 | MYLAN B.V | Netherlands | 1 | $69.58 | MYLAN LABORATORIES LTD | Tablet |
| 27 | EMIRATES POST GROUP | United Arab Emirates | 7 | $25.83 | PREMIER ENTERPRISE | Tablet |
| 28 | TORRENT PHARMA (MALTA) LTD | Malta | 2 | $1.57 | TORRENT PHARMACEUTIC… | Tablet |
This report covers 208 2025-Q4 Simvastatin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/simvastatin
Talk to our trade analyst
Need a custom simvastatin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/simvastatin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Simvastatin product page
Live data, supplier directory, price trends, and trade route analysis